SlideShare a Scribd company logo
1 of 62
FASTING TRIGLYCERIDES &
GLUCOSE INDEX
as a Diagnostic Test for
INSULIN RESISTANCE in Young Adults
Fernando Guerrero-Romero, Rafael Villalobos-Molina, J. Rafael Jimenez-Flores,
Luis E. Simental-Mendia, Rene Mendez-Cruz,b Miguel Murguıa-Romero, and
Martha Rodrıguez-Moran
Shendy – Fatma – Riska
Pembimbing: Dr. dr. Himawan Sanusi, SpPD-KEMD
Archives of Medical Research 47 (2016) 382-387
http://dx.doi.org/10.1016/j.arcmed.2016.08.012
INTRODUCTION
INSULIN RESISTANCE (IR)
• Precedes development of type 2 diabetes and
cardiovascular disease
 EARLY detection !!!
• Gold standard :
Euglycemic-hyperinsulinemic clamp
(Expensive & not available)
• Surrogate indices :
HOMA-IR
TyG index
2
INTRODUCTION
TyG index
• Different ethnic groups
– Mexican-Americans and Caucasian descents
– Koreans
– Chinese
– Mexican adults
– Italian
– Brazilian adults
 Useful  identification of IR
Best cost/performance ratio
• Younger adults ??
3
INTRODUCTION
Objective :
To evaluate
the TyG index
as a diagnostic test for IR
in healthy young adults
4
MATERIALS & METHODS
• Eligible subjects, healthy young adults
• College students
• 18 – 23 years
• Exclusion criteria:
– Pregnancy
– Chronic illness
– Malignancy
– Diabetes
– Intake of drugs during the previous 3 months
5
MATERIALS & METHODS
1st step
• Randomized n = 75
• TyG index vs the euglycemic-
hyperinsulinemic clamp test
2nd step
• Diagnostic concordance of TyG index and
HOMA-IR  overall population
6
MATERIALS & METHODS
• IR
– Euglycemic-hyperinsulinemic clamp  M rate ≥ 2.8
– HOMA-IR index ≥ 2.9
• Obesity
– BMI ≥ 30 kg/m2
• Overweight
– BMI ≥ 25 kg/m2
• Normal weight
– 19 kg/m2 ≤ BMI < 25 kg/m2
7
MATERIALS & mETHODS
8
𝐇𝐎𝐌𝐀 − 𝐈𝐑 =
𝐟𝐚𝐬𝐭𝐢𝐧𝐠 𝐢𝐧𝐬𝐮𝐥𝐢𝐧 (𝐔 𝐦𝐋) × 𝐟𝐚𝐬𝐭𝐢𝐧𝐠 𝐠𝐥𝐮𝐜𝐨𝐬𝐞 (𝐦𝐦𝐨𝐥 𝐋)
𝟐𝟐. 𝟓
TyG index =
Ln [fasting triglycerides (mg/dL) x fasting glucose (mg/dL)] / 2
𝐁𝐌𝐈 =
𝐰𝐞𝐢𝐠𝐡𝐭 (𝐤𝐠)
𝐡𝐞𝐢𝐠𝐡𝐭 (𝐦) 𝟐
MATERIALS & METHODS
• Whole blood
• 10 – 12 h overnight fasting
– Triglycerides
– Glucose
– Insulin
9
RESULTS
5,538 healthy young adults
Average age 19.2 ± 1.4 years
BMI 24.2 ± 4.4 kg/m2
10
3,795 (68.5%)
1,743 (31.5%)
Normal weight 3,632 (65,6%)
Overweight 1,355 (24.5%)
Obesity 551 (9.9%)
RESULTS
11
A total of 5,538 healthy young adults with an average age of 19.2 ± 1.4 years and
BMI of 24.2 ± 4.4 kg/m2 were enrolled. Of these subjects, 3,795 (68.5%) were
men and 1,743 (31.5%) women
RESULTS
75 participants
 45 (60%)
 30 (40%)
Normal weight 50 (66.7%)
Overweight 15 (20%)
Obesity 10 (13.3%)
12
TyG index vs euglycemic hyperinsulinemic
clamp
RESULTS
13
A total of 5,538 healthy young adults with an average age of 19.2 ± 1.4 years and
BMI of 24.2 ± 4.4 kg/m2 were enrolled. Of these subjects, 3,795 (68.5%) were
men and 1,743 (31.5%) women
RESULTS
• Pearson’s correlation coefficient between TyG index
and M rates :
  -0.875 ( p <0 .0001)
  -0.834 ( p < 0.0005)
• ROC scatter plot revealed that the best value of TyG
index for diagnosis of IR
  4.55
 4.68
14
RESULTS
15
Figure 1. Receiver operating characteristic curve. Sensitivity represents
true-positive results and 1-specificity the false-positive results. The best
TyG value for diagnosis of insulin resistance was 4.55 (sensitivity 0.687)
and 4.68 (sensitivity 0.673) for women (B) and men (A).


RESULTS
16
RESULTS
17
HOMA-IR
346
(9.1%)
278
(15.9%)
TyG index
374
(9.8%)
304
(17.4%)
Insulin resistance
RESULTS
Pearson correlation between the TyG and HOMA-IR
  0.932 ( p < 0.0005)
  0.918 ( p < 0.0005)
18
results
19
DISCUSSION
TyG index
•  NPV
•  NLR
• High diagnostic concordance with HOMA-IR
 Screening IR in young adults
Not a diagnostic test for confirming IR
20
DISCUSSION
TyG index
• Insulin  not available in all laboratories
• Minimize the cost of screening and expanding
its coverage
 Promissory tool for screening IR in
young adults
21
DISCUSSION
TyG index
6.2%
normal-weight
participants
HOMA-IR
5.6%
normal-weight
participants
22
Impaired insulin sensitivity
TyG index  useful for screening of
metabolically obese but normal-weight young adults
CONCLUSION
23
TyG index
High NPV
Low NLR
High diagnostic concordance
with HOMA-IR
Screening IR in young adults
26
For the euglycemic-hyperinsulinemic clamp technique, two points of
venous access were established. The first was placed in a retrograde
position into any vein in the subject’s hand through a 23-gauge
catheter to obtain blood samples. The hand was wrapped with a
thermal pillow until reaching a temperature above 40 C to improve the
amount of oxygen in venous blood. The second point of venous access
was established in the contralateral arm with a 20-gauge catheter for
infusion. Insulin (Humulin R; Eli Lilly Co., Mexico City, Mexico) was
given as a primed continuous infusion calculated to raise the plasma
insulin concentration to 100U/m2, followed by an insulin infusion rate
fixed at 40U/min/m2.Aconstant blood glucose level was maintained
(with a coefficient of variation5%)throughout the 120- min study by
infusing 10% glucose at various rates according to blood glucose
measurements performed at 5-min intervals. At the end of the clamp
procedure, the 10% glucose infusion was maintained for 30 min to
avoid hypoglycemia. Total glucose metabolism (M) rate was calculated
to evaluate insulin sensitivity (9). All of the studies began at 0800 h
after a 10- to 12-h overnight fast.Mrates of at least 2.8 defined insulin
resistance. 27
• Hyperinsulinemic Euglycemic Glucose Clamp Technique. After an
overnight fast, insulin is infused intravenously at a constant rate that
may range from 5~120 mU/m2/min (dose per body surface area per
minute). This constant insulin infusion results in a new steady-state
insulin level that is above the fasting level (hyperinsulinemic). As a
consequence, glucose disposal in skeletal muscle and adipose tissue is
increased while hepatic glucose production is suppressed. Under these
conditions, a bedside glucose analyzer is used to frequently monitor
blood glucose levels at 5~10 min intervals while 20% dextrose is given
intravenously at a variable rate in order to "clamp" blood glucose
concentrations in the normal range (euglycemic). An infusion of
potassium phosphate is also given to prevent hypokalemia resulting
from hyperinsulinemia and increased glucose disposal. After several
hours of constant insulin infusion, steady-state conditions can typically
be achieved for plasma insulin, blood glucose, and the glucose infusion
rate (GIR). Assuming that the hyperinsulinemic state is sufficient to
completely suppress hepatic glucose production, and since there is no
net change in blood glucose concentrations under steady-state clamp
conditions, the GIR must be equal to the glucose disposal rate (M).
Thus, whole body glucose disposal at a given level of hyperinsulinemia
can be directly determined (Adopted from Muniyappa R, et al. Am J
Physiol Endocrinol Metab 294:E15-26, 2008).
28
Jenis Pemeriksaan : Trigliserida
Metode : PAP – GPO
Prinsip : Trigliserida ditentukan setelah hidrolisis
enzim dengan lemak. Indikator quinoneimine dibentuk dari
hidrogen peroksida, 4 – aminoantypirine dan 4 – klorofenol di
bawah pengaruh katalisis peroksidase.
Trigliserida lipases gliserol + asam lemak
Gliserol + ATP GK gliserol-3-fosfat + ADP
Gliserol-3-fostat + O2 GPO dihidroksiaseton fosfat + H2O2
H2O2 + aminoantypirine POD quinoneimine + HCl + H2O +
4-Klorofenol
Metode dan prinsip tes glukosa
• Metode enzimatik :glucose oxidase / hexokinase
• Prinsip tes:
Darah kapiler diserap ke dalam strip tes, kemudian
mengalir ke area tes dan bercampur dengan reagen
untuk memulai proses pengukuran. Enzim Glucose
dehydrogenase dan koenzim dalam strip tes
mengkonversi glukosa dalam sampel darah menjadi
glukonolakton. Reaksi tersebut menghasilkan listrik
DC yang tidak berbahaya sehingga Meter mampu
mengukur gula darah.
Pengatur kadar glukosa dalam darah
MEKANISME KERJA INSULIN
Pemilihan hipotesis korelatif
Variabel 1 Variabel 2 Uji korelasi yang dipilih
Nominal Nominal Koefisien kontingensi, Lambda
Nominal Ordinal Koefisien kontingensi, Lambda
Ordinal Ordinal Spearman, Gamma, Somers’d
Ordinal Numerik Spearman
Numerik Numerik Pearson
53
Panduan interpretasi hasil uji hipotesis berdasarkan
kekuatan korelasi, nilai p dan arah korelasi
No Paramter Nilai Interpretasi
1
Kekuatan
korelasi (r)
0,0 sd < 0,2 Sangat lemah
0,2 sd < 0,4 Lemah
0,4 sd < 0,6 Sedang
0,6 sd < 0,8 Kuat
0,8 sd 1 Sangat kuat
2 Nilai p
P < 0,05 Terdapat korelasi yang bermakna antara dua
variabel yang diuji
P > 0,05 Tidak terdapat korelasi yang bermakna
antara dua variabel yang diuji
3 Arah korelasi
+ (positif) Searah, semakin besar nilai satu variabel
semakin besar pula nilai variabel lainnya.
- (negatif) Berlawanan arah. Semakin besar nilai satu
variabel, semakin kecil nilai variabel lainnya.
54
56
Sehat Sakit
Positif TP
(true positive)
FP
(false positive)
Negatif FN
(false negative)
TN
(true negative)
Sensitivity =
𝐓𝐏
(𝐓𝐏 + 𝐅𝐍)
Specificity =
𝐓𝐍
(𝐓𝐍 + 𝐅𝐏)
PPV =
𝐓𝐏
(𝐓𝐏 + 𝐅𝐏)
(positive predictive value)
NPV =
𝐓𝐍
(𝐓𝐍 + 𝐅𝐍)
(negative predictive value)
PLR =
𝐒𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲
(𝟏 −𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜𝐢𝐭𝐲)
(positive likelihood ratio)
NLR =
(𝟏 − 𝐒𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲)
𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜𝐢𝐭𝐲
(negative likelihood ratio)
57
60
d
SLIDE.pptx
SLIDE.pptx

More Related Content

What's hot

Diabetes mellitus management
Diabetes mellitus managementDiabetes mellitus management
Diabetes mellitus managementSameh Abdel-ghany
 
Diabetes mellitus an overview
Diabetes mellitus an overviewDiabetes mellitus an overview
Diabetes mellitus an overviewRuth Nwokoma
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes MellitusCarmela Domocmat
 
Role of diabetes education
Role of diabetes educationRole of diabetes education
Role of diabetes educationRiyad Banayot
 
C:\documents and settings\administrator\桌面\35 ndiabetes mellitus
C:\documents and settings\administrator\桌面\35 ndiabetes mellitusC:\documents and settings\administrator\桌面\35 ndiabetes mellitus
C:\documents and settings\administrator\桌面\35 ndiabetes mellitusinternalmed
 
Individualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenarioIndividualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenarioPrithvi Puwar
 
Laboratory diagnosis of Diabetes mellitus
Laboratory diagnosis of Diabetes mellitus Laboratory diagnosis of Diabetes mellitus
Laboratory diagnosis of Diabetes mellitus Monika Nema
 
World Diabetes Day
World Diabetes Day World Diabetes Day
World Diabetes Day Gopal Yadav
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusSara Ravi
 
New information on the use of HbA1c as a compensation criterion
New information on the use of HbA1c as a compensation criterionNew information on the use of HbA1c as a compensation criterion
New information on the use of HbA1c as a compensation criterionAleksandr Pkhakadze, MD, PhD
 
Diabetes mellitus presentation
Diabetes mellitus presentationDiabetes mellitus presentation
Diabetes mellitus presentationlakshmi das
 
SMBG (Self Monitoring of Blood Glucose)
SMBG (Self Monitoring of Blood Glucose)SMBG (Self Monitoring of Blood Glucose)
SMBG (Self Monitoring of Blood Glucose)Dr Joozer Rangwala
 
Managing your type ii diabetes: patient education
Managing your type ii diabetes: patient educationManaging your type ii diabetes: patient education
Managing your type ii diabetes: patient educationmdlv1974
 

What's hot (20)

Updates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr SelimUpdates of Diabetes Management by Dr Selim
Updates of Diabetes Management by Dr Selim
 
Diabetes mellitus management
Diabetes mellitus managementDiabetes mellitus management
Diabetes mellitus management
 
Life style modifications in Diabetes
Life style modifications in DiabetesLife style modifications in Diabetes
Life style modifications in Diabetes
 
Diabetes mellitus an overview
Diabetes mellitus an overviewDiabetes mellitus an overview
Diabetes mellitus an overview
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes Mellitus
 
Role of diabetes education
Role of diabetes educationRole of diabetes education
Role of diabetes education
 
C:\documents and settings\administrator\桌面\35 ndiabetes mellitus
C:\documents and settings\administrator\桌面\35 ndiabetes mellitusC:\documents and settings\administrator\桌面\35 ndiabetes mellitus
C:\documents and settings\administrator\桌面\35 ndiabetes mellitus
 
Individualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenarioIndividualized Diabetes treatment in Indian scenario
Individualized Diabetes treatment in Indian scenario
 
Managing Diabetes With Insulin by Dr Shahjada Selim
Managing DiabetesWith Insulin by Dr Shahjada SelimManaging DiabetesWith Insulin by Dr Shahjada Selim
Managing Diabetes With Insulin by Dr Shahjada Selim
 
Diabetes management
Diabetes managementDiabetes management
Diabetes management
 
Laboratory diagnosis of Diabetes mellitus
Laboratory diagnosis of Diabetes mellitus Laboratory diagnosis of Diabetes mellitus
Laboratory diagnosis of Diabetes mellitus
 
World Diabetes Day
World Diabetes Day World Diabetes Day
World Diabetes Day
 
Diabetes
DiabetesDiabetes
Diabetes
 
ADA 2022.pptx
ADA 2022.pptxADA 2022.pptx
ADA 2022.pptx
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
New information on the use of HbA1c as a compensation criterion
New information on the use of HbA1c as a compensation criterionNew information on the use of HbA1c as a compensation criterion
New information on the use of HbA1c as a compensation criterion
 
Diabetes mellitus presentation
Diabetes mellitus presentationDiabetes mellitus presentation
Diabetes mellitus presentation
 
SMBG (Self Monitoring of Blood Glucose)
SMBG (Self Monitoring of Blood Glucose)SMBG (Self Monitoring of Blood Glucose)
SMBG (Self Monitoring of Blood Glucose)
 
Managing your type ii diabetes: patient education
Managing your type ii diabetes: patient educationManaging your type ii diabetes: patient education
Managing your type ii diabetes: patient education
 
Metabolic Syndrome
 Metabolic Syndrome Metabolic Syndrome
Metabolic Syndrome
 

Similar to SLIDE.pptx

Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia drnarendragoel
 
Dr antuna de alaiz antuna-miami talk
Dr antuna de alaiz antuna-miami talkDr antuna de alaiz antuna-miami talk
Dr antuna de alaiz antuna-miami talkclinidiabet
 
Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...
Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...
Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...mahendrareddychirra
 
Metabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1cMetabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1cTanveer Fahim
 
High prevalence of metabolic syndrome among competitive exam appearing studen...
High prevalence of metabolic syndrome among competitive exam appearing studen...High prevalence of metabolic syndrome among competitive exam appearing studen...
High prevalence of metabolic syndrome among competitive exam appearing studen...iosrjce
 
Diabetes Mellitus treatment n mm.pptx
Diabetes Mellitus treatment n mm.pptxDiabetes Mellitus treatment n mm.pptx
Diabetes Mellitus treatment n mm.pptxJyotiChoudhary327194
 
Dr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumabDr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumabCampus Sanofi
 
DIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptx
DIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptxDIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptx
DIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptxSATKALPOKJA4
 
Empagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxEmpagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxpurraSameer
 
Biologia Molecular
Biologia MolecularBiologia Molecular
Biologia MolecularIsaupb
 
Seminario
SeminarioSeminario
SeminarioIsaupb
 
Seminario Isabel y Luis Carlos
Seminario Isabel y Luis CarlosSeminario Isabel y Luis Carlos
Seminario Isabel y Luis CarlosIsaupb
 
Hyperglyceminin Icu Md2008
Hyperglyceminin Icu Md2008Hyperglyceminin Icu Md2008
Hyperglyceminin Icu Md2008Surgical Review
 
A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...
A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...
A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...ijtsrd
 
Thyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptxThyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptxSyedFurqan30
 

Similar to SLIDE.pptx (20)

Neonatal hypoglycemia
Neonatal hypoglycemia Neonatal hypoglycemia
Neonatal hypoglycemia
 
A0460108
A0460108A0460108
A0460108
 
B04609014
B04609014B04609014
B04609014
 
Sugar Control in ICU
Sugar Control in ICUSugar Control in ICU
Sugar Control in ICU
 
Dr antuna de alaiz antuna-miami talk
Dr antuna de alaiz antuna-miami talkDr antuna de alaiz antuna-miami talk
Dr antuna de alaiz antuna-miami talk
 
Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...
Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...
Intake of Black Vinegar on Anthropometric Measures, Cardiometabolic Profiles,...
 
Metabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1cMetabolic syndrome vs HbA1c
Metabolic syndrome vs HbA1c
 
High prevalence of metabolic syndrome among competitive exam appearing studen...
High prevalence of metabolic syndrome among competitive exam appearing studen...High prevalence of metabolic syndrome among competitive exam appearing studen...
High prevalence of metabolic syndrome among competitive exam appearing studen...
 
Diabetes Mellitus treatment n mm.pptx
Diabetes Mellitus treatment n mm.pptxDiabetes Mellitus treatment n mm.pptx
Diabetes Mellitus treatment n mm.pptx
 
Literature Evaluation.pptx
Literature Evaluation.pptxLiterature Evaluation.pptx
Literature Evaluation.pptx
 
Dr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumabDr. Tinahones - Simposio lanzamiento alirocumab
Dr. Tinahones - Simposio lanzamiento alirocumab
 
DIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptx
DIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptxDIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptx
DIABETES MELLITUS TIPE 2 PIT PDUI 2019.pptx
 
1st pre sentation journal... 15feb.2015
1st pre sentation journal... 15feb.20151st pre sentation journal... 15feb.2015
1st pre sentation journal... 15feb.2015
 
Empagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxEmpagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptx
 
Biologia Molecular
Biologia MolecularBiologia Molecular
Biologia Molecular
 
Seminario
SeminarioSeminario
Seminario
 
Seminario Isabel y Luis Carlos
Seminario Isabel y Luis CarlosSeminario Isabel y Luis Carlos
Seminario Isabel y Luis Carlos
 
Hyperglyceminin Icu Md2008
Hyperglyceminin Icu Md2008Hyperglyceminin Icu Md2008
Hyperglyceminin Icu Md2008
 
A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...
A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...
A Review on Continuous Glucose Monitoring System A Competent Technique in Mon...
 
Thyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptxThyroid dysfunction and insulin resistance journal ppt.pptx
Thyroid dysfunction and insulin resistance journal ppt.pptx
 

Recently uploaded

JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTThomas Onyango Kirengo
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUELMKARTHIKEMMANUEL
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...JRRolfNeuqelet
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsNaveen Gokul Dr
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024locantocallgirl01
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSachin Sharma
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfDr. Nasir Mustafa
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfLearnyoga
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
 
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfUnveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfNoorulainMehmood1
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failuremahiavy26
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessGokuldas Hospital
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalGokuldas Hospital
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxDr. Rabia Inam Gandapore
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialSherrylee83
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersShafnaP5
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesPHARMA IQ EDUCATION
 

Recently uploaded (20)

JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUELCONGENITAL HYPERTROPHIC PYLORIC STENOSIS  by Dr M.KARTHIK EMMANUEL
CONGENITAL HYPERTROPHIC PYLORIC STENOSIS by Dr M.KARTHIK EMMANUEL
 
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
VIII.1 Nursing Interventions to Promote Healthy Psychological responses, SELF...
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
parliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdfparliaments-for-health-security_RecordOfAchievement.pdf
parliaments-for-health-security_RecordOfAchievement.pdf
 
Benefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdfBenefits of Chanting Hanuman Chalisa .pdf
Benefits of Chanting Hanuman Chalisa .pdf
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdfUnveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
Unveiling Pharyngitis: Causes, Symptoms, Diagnosis, and Treatment Strategies.pdf
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Histopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseasesHistopathological staining techniques used in liver diseases
Histopathological staining techniques used in liver diseases
 

SLIDE.pptx

  • 1. FASTING TRIGLYCERIDES & GLUCOSE INDEX as a Diagnostic Test for INSULIN RESISTANCE in Young Adults Fernando Guerrero-Romero, Rafael Villalobos-Molina, J. Rafael Jimenez-Flores, Luis E. Simental-Mendia, Rene Mendez-Cruz,b Miguel Murguıa-Romero, and Martha Rodrıguez-Moran Shendy – Fatma – Riska Pembimbing: Dr. dr. Himawan Sanusi, SpPD-KEMD Archives of Medical Research 47 (2016) 382-387 http://dx.doi.org/10.1016/j.arcmed.2016.08.012
  • 2. INTRODUCTION INSULIN RESISTANCE (IR) • Precedes development of type 2 diabetes and cardiovascular disease  EARLY detection !!! • Gold standard : Euglycemic-hyperinsulinemic clamp (Expensive & not available) • Surrogate indices : HOMA-IR TyG index 2
  • 3. INTRODUCTION TyG index • Different ethnic groups – Mexican-Americans and Caucasian descents – Koreans – Chinese – Mexican adults – Italian – Brazilian adults  Useful  identification of IR Best cost/performance ratio • Younger adults ?? 3
  • 4. INTRODUCTION Objective : To evaluate the TyG index as a diagnostic test for IR in healthy young adults 4
  • 5. MATERIALS & METHODS • Eligible subjects, healthy young adults • College students • 18 – 23 years • Exclusion criteria: – Pregnancy – Chronic illness – Malignancy – Diabetes – Intake of drugs during the previous 3 months 5
  • 6. MATERIALS & METHODS 1st step • Randomized n = 75 • TyG index vs the euglycemic- hyperinsulinemic clamp test 2nd step • Diagnostic concordance of TyG index and HOMA-IR  overall population 6
  • 7. MATERIALS & METHODS • IR – Euglycemic-hyperinsulinemic clamp  M rate ≥ 2.8 – HOMA-IR index ≥ 2.9 • Obesity – BMI ≥ 30 kg/m2 • Overweight – BMI ≥ 25 kg/m2 • Normal weight – 19 kg/m2 ≤ BMI < 25 kg/m2 7
  • 8. MATERIALS & mETHODS 8 𝐇𝐎𝐌𝐀 − 𝐈𝐑 = 𝐟𝐚𝐬𝐭𝐢𝐧𝐠 𝐢𝐧𝐬𝐮𝐥𝐢𝐧 (𝐔 𝐦𝐋) × 𝐟𝐚𝐬𝐭𝐢𝐧𝐠 𝐠𝐥𝐮𝐜𝐨𝐬𝐞 (𝐦𝐦𝐨𝐥 𝐋) 𝟐𝟐. 𝟓 TyG index = Ln [fasting triglycerides (mg/dL) x fasting glucose (mg/dL)] / 2 𝐁𝐌𝐈 = 𝐰𝐞𝐢𝐠𝐡𝐭 (𝐤𝐠) 𝐡𝐞𝐢𝐠𝐡𝐭 (𝐦) 𝟐
  • 9. MATERIALS & METHODS • Whole blood • 10 – 12 h overnight fasting – Triglycerides – Glucose – Insulin 9
  • 10. RESULTS 5,538 healthy young adults Average age 19.2 ± 1.4 years BMI 24.2 ± 4.4 kg/m2 10 3,795 (68.5%) 1,743 (31.5%) Normal weight 3,632 (65,6%) Overweight 1,355 (24.5%) Obesity 551 (9.9%)
  • 11. RESULTS 11 A total of 5,538 healthy young adults with an average age of 19.2 ± 1.4 years and BMI of 24.2 ± 4.4 kg/m2 were enrolled. Of these subjects, 3,795 (68.5%) were men and 1,743 (31.5%) women
  • 12. RESULTS 75 participants  45 (60%)  30 (40%) Normal weight 50 (66.7%) Overweight 15 (20%) Obesity 10 (13.3%) 12 TyG index vs euglycemic hyperinsulinemic clamp
  • 13. RESULTS 13 A total of 5,538 healthy young adults with an average age of 19.2 ± 1.4 years and BMI of 24.2 ± 4.4 kg/m2 were enrolled. Of these subjects, 3,795 (68.5%) were men and 1,743 (31.5%) women
  • 14. RESULTS • Pearson’s correlation coefficient between TyG index and M rates :   -0.875 ( p <0 .0001)   -0.834 ( p < 0.0005) • ROC scatter plot revealed that the best value of TyG index for diagnosis of IR   4.55  4.68 14
  • 15. RESULTS 15 Figure 1. Receiver operating characteristic curve. Sensitivity represents true-positive results and 1-specificity the false-positive results. The best TyG value for diagnosis of insulin resistance was 4.55 (sensitivity 0.687) and 4.68 (sensitivity 0.673) for women (B) and men (A).  
  • 18. RESULTS Pearson correlation between the TyG and HOMA-IR   0.932 ( p < 0.0005)   0.918 ( p < 0.0005) 18
  • 20. DISCUSSION TyG index •  NPV •  NLR • High diagnostic concordance with HOMA-IR  Screening IR in young adults Not a diagnostic test for confirming IR 20
  • 21. DISCUSSION TyG index • Insulin  not available in all laboratories • Minimize the cost of screening and expanding its coverage  Promissory tool for screening IR in young adults 21
  • 22. DISCUSSION TyG index 6.2% normal-weight participants HOMA-IR 5.6% normal-weight participants 22 Impaired insulin sensitivity TyG index  useful for screening of metabolically obese but normal-weight young adults
  • 23. CONCLUSION 23 TyG index High NPV Low NLR High diagnostic concordance with HOMA-IR Screening IR in young adults
  • 24.
  • 25.
  • 26. 26
  • 27. For the euglycemic-hyperinsulinemic clamp technique, two points of venous access were established. The first was placed in a retrograde position into any vein in the subject’s hand through a 23-gauge catheter to obtain blood samples. The hand was wrapped with a thermal pillow until reaching a temperature above 40 C to improve the amount of oxygen in venous blood. The second point of venous access was established in the contralateral arm with a 20-gauge catheter for infusion. Insulin (Humulin R; Eli Lilly Co., Mexico City, Mexico) was given as a primed continuous infusion calculated to raise the plasma insulin concentration to 100U/m2, followed by an insulin infusion rate fixed at 40U/min/m2.Aconstant blood glucose level was maintained (with a coefficient of variation5%)throughout the 120- min study by infusing 10% glucose at various rates according to blood glucose measurements performed at 5-min intervals. At the end of the clamp procedure, the 10% glucose infusion was maintained for 30 min to avoid hypoglycemia. Total glucose metabolism (M) rate was calculated to evaluate insulin sensitivity (9). All of the studies began at 0800 h after a 10- to 12-h overnight fast.Mrates of at least 2.8 defined insulin resistance. 27
  • 28. • Hyperinsulinemic Euglycemic Glucose Clamp Technique. After an overnight fast, insulin is infused intravenously at a constant rate that may range from 5~120 mU/m2/min (dose per body surface area per minute). This constant insulin infusion results in a new steady-state insulin level that is above the fasting level (hyperinsulinemic). As a consequence, glucose disposal in skeletal muscle and adipose tissue is increased while hepatic glucose production is suppressed. Under these conditions, a bedside glucose analyzer is used to frequently monitor blood glucose levels at 5~10 min intervals while 20% dextrose is given intravenously at a variable rate in order to "clamp" blood glucose concentrations in the normal range (euglycemic). An infusion of potassium phosphate is also given to prevent hypokalemia resulting from hyperinsulinemia and increased glucose disposal. After several hours of constant insulin infusion, steady-state conditions can typically be achieved for plasma insulin, blood glucose, and the glucose infusion rate (GIR). Assuming that the hyperinsulinemic state is sufficient to completely suppress hepatic glucose production, and since there is no net change in blood glucose concentrations under steady-state clamp conditions, the GIR must be equal to the glucose disposal rate (M). Thus, whole body glucose disposal at a given level of hyperinsulinemia can be directly determined (Adopted from Muniyappa R, et al. Am J Physiol Endocrinol Metab 294:E15-26, 2008). 28
  • 29.
  • 30. Jenis Pemeriksaan : Trigliserida Metode : PAP – GPO Prinsip : Trigliserida ditentukan setelah hidrolisis enzim dengan lemak. Indikator quinoneimine dibentuk dari hidrogen peroksida, 4 – aminoantypirine dan 4 – klorofenol di bawah pengaruh katalisis peroksidase. Trigliserida lipases gliserol + asam lemak Gliserol + ATP GK gliserol-3-fosfat + ADP Gliserol-3-fostat + O2 GPO dihidroksiaseton fosfat + H2O2 H2O2 + aminoantypirine POD quinoneimine + HCl + H2O + 4-Klorofenol
  • 31.
  • 32.
  • 33.
  • 34. Metode dan prinsip tes glukosa • Metode enzimatik :glucose oxidase / hexokinase • Prinsip tes: Darah kapiler diserap ke dalam strip tes, kemudian mengalir ke area tes dan bercampur dengan reagen untuk memulai proses pengukuran. Enzim Glucose dehydrogenase dan koenzim dalam strip tes mengkonversi glukosa dalam sampel darah menjadi glukonolakton. Reaksi tersebut menghasilkan listrik DC yang tidak berbahaya sehingga Meter mampu mengukur gula darah.
  • 35.
  • 36.
  • 37. Pengatur kadar glukosa dalam darah
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53. Pemilihan hipotesis korelatif Variabel 1 Variabel 2 Uji korelasi yang dipilih Nominal Nominal Koefisien kontingensi, Lambda Nominal Ordinal Koefisien kontingensi, Lambda Ordinal Ordinal Spearman, Gamma, Somers’d Ordinal Numerik Spearman Numerik Numerik Pearson 53
  • 54. Panduan interpretasi hasil uji hipotesis berdasarkan kekuatan korelasi, nilai p dan arah korelasi No Paramter Nilai Interpretasi 1 Kekuatan korelasi (r) 0,0 sd < 0,2 Sangat lemah 0,2 sd < 0,4 Lemah 0,4 sd < 0,6 Sedang 0,6 sd < 0,8 Kuat 0,8 sd 1 Sangat kuat 2 Nilai p P < 0,05 Terdapat korelasi yang bermakna antara dua variabel yang diuji P > 0,05 Tidak terdapat korelasi yang bermakna antara dua variabel yang diuji 3 Arah korelasi + (positif) Searah, semakin besar nilai satu variabel semakin besar pula nilai variabel lainnya. - (negatif) Berlawanan arah. Semakin besar nilai satu variabel, semakin kecil nilai variabel lainnya. 54
  • 55.
  • 56. 56 Sehat Sakit Positif TP (true positive) FP (false positive) Negatif FN (false negative) TN (true negative) Sensitivity = 𝐓𝐏 (𝐓𝐏 + 𝐅𝐍) Specificity = 𝐓𝐍 (𝐓𝐍 + 𝐅𝐏) PPV = 𝐓𝐏 (𝐓𝐏 + 𝐅𝐏) (positive predictive value) NPV = 𝐓𝐍 (𝐓𝐍 + 𝐅𝐍) (negative predictive value) PLR = 𝐒𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲 (𝟏 −𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜𝐢𝐭𝐲) (positive likelihood ratio) NLR = (𝟏 − 𝐒𝐞𝐧𝐬𝐢𝐭𝐢𝐯𝐢𝐭𝐲) 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜𝐢𝐭𝐲 (negative likelihood ratio)
  • 57. 57
  • 58.
  • 59.
  • 60. 60 d